2010
DOI: 10.1016/j.jaci.2009.10.018
|View full text |Cite
|
Sign up to set email alerts
|

Early-life chlamydial lung infection enhances allergic airways disease through age-dependent differences in immunopathology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

13
143
1

Year Published

2010
2010
2020
2020

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 99 publications
(157 citation statements)
references
References 55 publications
13
143
1
Order By: Relevance
“…Lung measurements were taken shortly after the mice were exposed to methacholine. All of these methods have been described previously (14,33,34).…”
Section: Histochemistry and Enzyme Cytochemistry Evaluation Of The MCmentioning
confidence: 99%
“…Lung measurements were taken shortly after the mice were exposed to methacholine. All of these methods have been described previously (14,33,34).…”
Section: Histochemistry and Enzyme Cytochemistry Evaluation Of The MCmentioning
confidence: 99%
“…107 No adoptive transfer experiments were performed to test the in vivo function of the DCs in that study. We also found that, although DCs from adult mice with neonatal exposure to killed bacteria inhibited the development of allergic reactions in recipient mice after adoptive transfer, DCs from young mice with short exposure to the same bacteria failed to inhibit the development of allergic reactions; this failure was associated with the lack of IL-10 production by the latter DCs (Jiao L, Yang X, unpubl.…”
Section: Cd25mentioning
confidence: 99%
“…Recently, extensive research has focused on the significance of both the nature and timing of respiratory infections in asthma, and whether infection-induced skewing of the T-cell phenotype can influence the progression of asthma [4][5][6][7][8].…”
mentioning
confidence: 99%
“…Although certain types of infections drive and/or exacerbate asthma [6][7][8][9][10], several studies support a role for some respiratory infections, such as mycobacterial infections, in suppressing Th2-driven allergic disease [4,11]. Administration of mycobacterial components inhibits allergic airway disease (AAD); however, the efficacy of mycobacterial treatment in preventing allergic diseases in human trials has been varied, with decreases in the severity of atopic dermatitis but no affect on allergic asthma [11][12][13].…”
mentioning
confidence: 99%